Lisinopril and Campath drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lisinopril (lisinopril) and Campath (alemtuzumab). Common drug interactions include dizziness among females and hypoxia among males.

The phase IV clinical study analyzes what interactions people have when they take Lisinopril and Campath. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,654 Lisinopril users. Check the latest studies of Lisinopril.

What is Campath?

Campath has active ingredients of alemtuzumab. eHealthMe is studying from 4,909 Campath users. Check the latest studies of Campath.



On Jul, 14, 2026

49 people who take Lisinopril and Campath together, and have interactions are studied.

Lisinopril and Campath drug interactions.

What are the common drug interactions of Lisinopril and Campath, by gender? *:

female:

  1. Dizziness
  2. Drug ineffective
  3. Dyspnoea (difficult or laboured respiration)
  4. Hearing impaired
  5. Heart rate decreased
  6. Hypoxia (low oxygen in tissues)
  7. Lower respiratory tract infection
  8. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  9. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  10. Oesophageal candidiasis (fungal infection of oesophagus)

male:

  1. Hypoxia (low oxygen in tissues)
  2. Haemorrhage (bleeding)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Bacteraemia (presence of bacteria in the blood)
  5. Back pain
  6. Rigors (an episode of shaking or exaggerated shivering)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Cardiac arrest
  9. Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
  10. Febrile neutropenia (fever with reduced white blood cells)

What are the common drug interactions of Lisinopril and Campath, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Drug ineffective
  2. Hearing impaired
  3. Lower respiratory tract infection
  4. Oesophageal candidiasis (fungal infection of oesophagus)
  5. Pericardial effusion (fluid around the heart)
  6. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
  10. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)

20-29:

  1. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  2. Pulmonary oedema (fluid accumulation in the lungs)

30-39:

  1. Abdominal pain
  2. Cholecystitis (infection of gallbladder)
  3. Troponin increased

40-49:

  1. Bk virus infection
  2. Cystitis haemorrhagic (blood in the urine and painful voiding)

50-59:

  1. Coagulopathy (blood's ability to clot is impaired)
  2. Haemorrhage (bleeding)
  3. Hepatic failure (liver failure)
  4. Hypotension (abnormally low blood pressure)
  5. Hypoxia (low oxygen in tissues)
  6. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  7. Multi-organ failure (multisystem organ failure)
  8. Oropharyngeal blistering (blister of oropharynx)
  9. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  10. Pyrexia (fever)

60+:

  1. Rigors (an episode of shaking or exaggerated shivering)
  2. Back pain
  3. Blood lactate dehydrogenase increased
  4. Calculus urinary (stone in urinary system)
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Hepatomegaly (abnormal enlargement of the liver)
  7. Hydrocele
  8. Nausea (feeling of having an urge to vomit)
  9. Oesophageal disorder (disease of oesophagus)
  10. Oxygen saturation decreased

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 17 people, 34.69%
  2. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 8 people, 16.33%
  3. Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 6.12%
  4. Periodontal Disease (disease that attacks the gum and bone and around the teeth): 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Lisinopril and Campath?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lisinopril and Campath:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lisinopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Campath:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lisinopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Campath and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lisinopril and alemtuzumab (the active ingredients of Lisinopril and Campath, respectively), and Lisinopril and Campath (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: